Cyclodextrin Nanoparticles and Injectable Polymer-Nanoparticle Hydrogels for Macrophage-Targeted Delivery of...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Small-molecule drugs are crucial therapeutics but face challenges with poor pharmacokinetics and off-target effects.
• Macrophages are key targets for immune modulation and treating various diseases.
• Current drug delivery methods often lead to rapid clearance and nonspecific biodistribution.

Purpose of the Study:

• To develop a macrophage-targeted nanoparticulate carrier for improved small-molecule drug delivery.
• To create an injectable polymer-nanoparticle (iPNP) hydrogel for localized and sustained drug release.
• To enhance therapeutic efficacy by concentrating drug effects at target sites and minimizing systemic exposure.

Main Methods:

• Preparation of cyclodextrin nanoparticles (CDNP) to encapsulate hydrophobic small-molecule drugs.
• Formulation of an injectable polymer-nanoparticle (iPNP) hydrogel system.
• Characterization of nanoparticle and hydrogel properties for drug delivery applications.

Main Results:

• Successfully synthesized cyclodextrin nanoparticles (CDNP) capable of housing hydrophobic small-molecule drugs.
• Developed an injectable polymer-nanoparticle (iPNP) hydrogel for sustained local drug delivery.
• Demonstrated potential for targeted delivery to macrophages and improved therapeutic outcomes.

Conclusions:

• The developed CDNP and iPNP hydrogel systems offer a promising strategy for targeted small-molecule drug delivery.
• These novel carriers can overcome pharmacokinetic limitations and reduce off-target effects.
• The systems are versatile for a wide range of therapeutic applications targeting macrophages.